KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 2 filers reported holding KYMERA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,137,924 | -44.2% | 81,865 | -7.7% | 0.02% | -39.3% |
| Q2 2023 | $2,039,949 | -23.1% | 88,732 | -0.9% | 0.03% | -36.4% |
| Q1 2023 | $2,651,766 | +17.8% | 89,496 | -0.8% | 0.04% | +4.8% |
| Q4 2022 | $2,251,043 | +27.3% | 90,186 | +11.1% | 0.04% | +35.5% |
| Q3 2022 | $1,768,000 | -5.6% | 81,194 | -14.6% | 0.03% | -6.1% |
| Q2 2022 | $1,872,000 | -61.4% | 95,073 | -17.0% | 0.03% | -26.7% |
| Q1 2022 | $4,846,000 | -36.4% | 114,506 | -4.5% | 0.04% | +4.7% |
| Q4 2021 | $7,616,000 | -1.6% | 119,953 | -8.9% | 0.04% | +7.5% |
| Q3 2021 | $7,736,000 | +46.9% | 131,694 | +21.3% | 0.04% | +53.8% |
| Q2 2021 | $5,266,000 | – | 108,578 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |